PT-141 20mg
GHH Pharma Grade
The Desire Activator

PT-141 20mg

Bremelanotide — CNS-driven libido enhancement for men & women

AED 749.00
Physician Required

PT-141 (Bremelanotide) is a melanocortin receptor agonist originally developed from the tanning peptide Melanotan II. Unlike PDE5 inhibitors (Viagra/Cialis), PT-141 works centrally through the brain's melanocortin system to enhance sexual desire and arousal in both men and women — addressing the neurological root of sexual dysfunction.

💉
Injectable / Oral
Administration
⏱️
2–4 weeks
First Results
🔄
Use as needed — allow 48–72 hours between doses
Cycle Length
🎯

Clinical Uses

What conditions & goals this peptide addresses

Hypoactive sexual desire disorder (HSDD)
Erectile dysfunction (non-vascular)
Female sexual arousal disorder
Low libido from stress, hormones, or antidepressants
Performance anxiety & sexual confidence

Key Benefits

The measurable outcomes you can expect

Increases sexual desire in men & women
Enhances arousal & sensitivity
Works centrally (brain) — not just vascular
Effective even when PDE5 inhibitors fail
No cardiovascular contraindications with nitrates
FDA-approved version (Vyleesi) for HSDD in women
🔬

How It Works — Mechanism of Action

The precise biology behind this peptide's effects

PT-141 activates melanocortin MC3-R and MC4-R receptors in the hypothalamus, triggering dopamine release in the limbic system — the brain's desire and reward centre. This central mechanism creates genuine sexual desire rather than simply increasing blood flow to genital tissues.

Administration Guide

Subcutaneous injection: Use insulin syringe, inject into abdomen or thigh. Nasal spray: 1–2 sprays per nostril 45–90 minutes before desired effect. Take on an empty or light stomach for best results.

💊

Dosage Protocol

GHH physician-guided dosing guidelines

Injectable: 1–2 mg subcutaneous, 1–2 hours before activity. Start at 1 mg to assess tolerance. Nasal: 10 mg spray, 1–2 sprays. Do not exceed 3× per week to avoid receptor desensitization.

🔄
Cycle Length
Use as needed — allow 48–72 hours between doses
🧊
Storage
Lyophilized: Room temperature. Reconstituted: Refrigerate 2–8°C, use within 30 days.

When to Expect Results

A realistic timeline from first dose to full effect

Onset: 30–60 minutes (injection) or 45–90 minutes (nasal). Duration: 6–12 hours. Effects felt the same day.

Day 1–7
Week 2–4
Week 4–8
Week 8–16
⚠️

Side Effects

What to watch for and how common they are

Nausea (most common, transient 1–2 hours), flushing, mild headache, transient increase in blood pressure. Darkening of moles/skin (rare with regular use).

🚫

Contraindications

Who should not use this peptide

Uncontrolled hypertension. Pregnancy. Concurrent use of vasodilators. History of melanoma.

Best Stacked With

Peptide synergies recommended by GHH physicians

Oxytocin for bonding & emotional intimacy Kisspeptin for hormonal support

Compare this peptide side-by-side

See how it stacks up against other protocols

🩺

Ready to Start Your PT-141 Protocol?

All peptide protocols require a physician consultation and blood work. Our licensed UAE physicians will craft a personalised plan for you.

The Science of Peptides

Understanding Your Body's Language

Peptides are not exotic foreign chemicals — they are the precise molecular signals your body has evolved to use for billions of years. Here's what you need to know.

🔭
"Peptides don't change who you are — they restore who you were designed to be."

— German Health Hub Clinical Philosophy

All peptides require UAE licensed physician review and mandatory blood work before dispensing. Information presented is for educational purposes only and does not constitute medical advice. Individual results may vary. Peptides are prescribed and dispensed under strict medical supervision by German Health Hub's licensed clinical team.